Silvana Perretta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Silvana Perretta has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
Bernard Dallemagne
IRCAD, Research Institute against Digestive Cancer, Strasbourg, France
9 shared publicationsJacques Marescaux
Research Institute Against Digestive Cancer (IRCAD), Strasbourg, France
9 shared publications- Jacques Marescaux
Research Institute against Digestive Cancer (IRCAD), 67091 Strasbourg, France
8 shared publications - Bernard Dallemagne
Research Institute against Digestive Cancer (IRCAD), 1 Place de l’Hôpital, 67000 Strasbourg, France
6 shared publications - Elisa Reitano
Department of General Surgery, Nouvel Hôpital Civil, CHRU-Strasbourg, Strasbourg, France
5 shared publications - Pierre Allemann
Department of Visceral Surgery, University Hospital CHUV, Rue Du Bugnon 46, 1011, Lausanne, Switzerland
5 shared publications
Latest Publications
- 31 August 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (10) , 1082-1083
Beyond gastric remodeling
- 31 August 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (10) , 1082-1083
Beyond gastric remodeling
- 23 July 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (8) , 7255-7264
Development of expert consensus protocols for diagnostic and procedural use of the EndoFLIP system
- 23 July 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (8) , 7255-7264
Development of expert consensus protocols for diagnostic and procedural use of the EndoFLIP system
- 11 July 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (8) , 4347-4351
First Case Series on Ambulatorial Endoscopic Sleeve Gastroplasty for Morbidity Obesity: A Single Center Experience
Background Endoscopic Sleeve Gastroplasty (ESG) is a minimally invasive endoscopic weight-loss procedure. Its outpatient application can reduce hospital stays and speed up recovery. The aim of this study is to compare ambulatory and hospitalized patients, identify predictors of hospitalization, and assess the safety and feasibility of outpatient ESG. Methods From November 2016 to April 2025, we performed 430 ESG procedures, with 228 (53%) completed in an ambulatory setting and 202 (47%) requiring hospitalization. We retrospectively analysed demographic and procedural data. Continuous variables were compared by independent sample Kruskal-Wallis test, while categorical variables were analysed using Pearson’s chi-squared test. Logistic regression model was used to identify predictors of hospitalization. Results The cohort included 97 males (22.7%) and 333 females (77.4%), with a mean age of 43 years [IQR 33–52], mean weight of 108 kg [IQR 95–123], and a mean BMI of 38.67 [IQR 35.57–42.99]. The mean operative time was 29 min [IQR 24–37]. Comparative analyses between ambulatory and hospitalized patients are summarized in Table 1, identifying age, BMI, general anaesthesia, and ASA class as predictors of hospitalization. Among the 228 ambulatory patients, 9 (4%) required unplanned postoperative admission. These patients demonstrated lower Chung scores at reassessment, primarily due to nausea and pain. No differences were observed in preoperative variables. Conclusion Ambulatory ESG is a safe, effective, and efficient option for selected patients, with a low rate of post-procedure hospitalization, representing a promising approach in bariatric endoscopy.
- 11 July 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (8) , 4347-4351
First Case Series on Ambulatorial Endoscopic Sleeve Gastroplasty for Morbidity Obesity: A Single Center Experience
Background Endoscopic Sleeve Gastroplasty (ESG) is a minimally invasive endoscopic weight-loss procedure. Its outpatient application can reduce hospital stays and speed up recovery. The aim of this study is to compare ambulatory and hospitalized patients, identify predictors of hospitalization, and assess the safety and feasibility of outpatient ESG. Methods From November 2016 to April 2025, we performed 430 ESG procedures, with 228 (53%) completed in an ambulatory setting and 202 (47%) requiring hospitalization. We retrospectively analysed demographic and procedural data. Continuous variables were compared by independent sample Kruskal-Wallis test, while categorical variables were analysed using Pearson’s chi-squared test. Logistic regression model was used to identify predictors of hospitalization. Results The cohort included 97 males (22.7%) and 333 females (77.4%), with a mean age of 43 years [IQR 33–52], mean weight of 108 kg [IQR 95–123], and a mean BMI of 38.67 [IQR 35.57–42.99]. The mean operative time was 29 min [IQR 24–37]. Comparative analyses between ambulatory and hospitalized patients are summarized in Table 1, identifying age, BMI, general anaesthesia, and ASA class as predictors of hospitalization. Among the 228 ambulatory patients, 9 (4%) required unplanned postoperative admission. These patients demonstrated lower Chung scores at reassessment, primarily due to nausea and pain. No differences were observed in preoperative variables. Conclusion Ambulatory ESG is a safe, effective, and efficient option for selected patients, with a low rate of post-procedure hospitalization, representing a promising approach in bariatric endoscopy.
- Open Access
From Surgery to Endoscopy: Comprehensive Review of Bariatric Approaches in Pediatric and Adolescent Patients
Background and Objectives: Pediatric and adolescent obesity is a growing global health concern that is often associated with cardiometabolic comorbidities. Lifestyle interventions represent first-line therapy; however, many adolescents with moderate-to-severe obesity fail to achieve clinically meaningful weight loss. The objective of this review is to provide a comprehensive overview of surgical and endoscopic interventions for adolescent obesity. Materials and Methods: A structured search of PubMed, Scopus, Web of Science and the Cochrane Library was conducted. Studies reporting outcomes of bariatric surgery (sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), adjustable gastric banding (AGB)) and endoscopic interventions (endoscopic sleeve gastroplasty (ESG) and intragastric balloons (IGBs)) in patients ≤ 21 years were included. Data on weight loss, BMI reduction, metabolic outcomes, adverse events and follow-up were extracted and summarized. Results: Bariatric surgery remains the most effective intervention, with SG and RYGB achieving substantial and durable weight loss and high rates of comorbidity remission. ESG is an emerging intervention with preliminary short-term efficacy and safety data, though evidence is limited to small pediatric cohorts. IGBs provide reversible, non-surgical weight reduction with consistent short-term efficacy, but long-term durability is variable and largely dependent on adherence to behavioral programs. Across all interventions, psychosocial support, family involvement and multidisciplinary care significantly influence the outcomes. Conclusions: Procedural interventions play a pivotal role in adolescents with moderate-to-severe obesity. IGBs could represent a minimally invasive, reversible option, particularly as bridging or adjunctive therapy. Prospective, long-term studies are needed to optimize patient selection, evaluate developmental safety and determine sustainable outcomes.
Open AccessFrom Surgery to Endoscopy: Comprehensive Review of Bariatric Approaches in Pediatric and Adolescent Patients
Background and Objectives: Pediatric and adolescent obesity is a growing global health concern that is often associated with cardiometabolic comorbidities. Lifestyle interventions represent first-line therapy; however, many adolescents with moderate-to-severe obesity fail to achieve clinically meaningful weight loss. The objective of this review is to provide a comprehensive overview of surgical and endoscopic interventions for adolescent obesity. Materials and Methods: A structured search of PubMed, Scopus, Web of Science and the Cochrane Library was conducted. Studies reporting outcomes of bariatric surgery (sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), adjustable gastric banding (AGB)) and endoscopic interventions (endoscopic sleeve gastroplasty (ESG) and intragastric balloons (IGBs)) in patients ≤ 21 years were included. Data on weight loss, BMI reduction, metabolic outcomes, adverse events and follow-up were extracted and summarized. Results: Bariatric surgery remains the most effective intervention, with SG and RYGB achieving substantial and durable weight loss and high rates of comorbidity remission. ESG is an emerging intervention with preliminary short-term efficacy and safety data, though evidence is limited to small pediatric cohorts. IGBs provide reversible, non-surgical weight reduction with consistent short-term efficacy, but long-term durability is variable and largely dependent on adherence to behavioral programs. Across all interventions, psychosocial support, family involvement and multidisciplinary care significantly influence the outcomes. Conclusions: Procedural interventions play a pivotal role in adolescents with moderate-to-severe obesity. IGBs could represent a minimally invasive, reversible option, particularly as bridging or adjunctive therapy. Prospective, long-term studies are needed to optimize patient selection, evaluate developmental safety and determine sustainable outcomes.
- Top Cited Papers
- 2 January 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (2) , 874-886
Effectiveness of Transoral Outlet Reduction Post-Roux-en-Y Gastric Bypass Beyond the One-Year Benchmark: A Systematic Review and Meta-Analysis
Background Transoral outlet reduction (TORe) is increasingly performed for recurrent weight gain or suboptimal clinical response after Roux-en-Y gastric bypass (RYGB). However, the durability of outcomes beyond one year remains uncertain. Methods A systematic review and meta-analysis was conducted following PRISMA guidelines. Six databases were searched to June 2025 for RCTs and cohort studies of adults undergoing TORe after RYGB with ≥ 12 months of follow-up. Outcomes included % total weight loss (%TWL), % excess weight loss (%EWL), and adverse events (AEs). Data were pooled using random effects restricted maximum likelihood models. Results Twenty-five studies (3 RCTs, 22 observational; 2667 patients) were included. Pooled baseline age was 47.3 years, 86.0% were female, mean BMI was 38.0 kg/m², and mean interval from RYGB to TORe was 9.5 years. At 12 months, pooled %TWL was 8.0% (95% CI 6.3–9.7) and pooled %EWL was 20.3% (95% CI 14.1–26.5). Weight loss declined at longer follow-up, with pooled estimates of 7.7% TWL and 16.3% EWL at 24 months, and 4% TWL at 36 months. In meta-regression, years since RYGB predicted greater %TWL and %EWL. The pooled AE rate was 5% (95% CI 3–7%), and the pooled SAE rate was 0.3% (95% CI 0.1–0.5%), with no procedure-related mortality. Conclusion TORe can provide modest but clinically meaningful weight loss at 12 months with a low rate of serious AE although durability beyond two years appears limited. It may be best regarded as an anatomically corrective intervention that is most effective when incorporated into comprehensive, long-term obesity management.
- 2 January 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (2) , 874-886
Top Cited PapersEffectiveness of Transoral Outlet Reduction Post-Roux-en-Y Gastric Bypass Beyond the One-Year Benchmark: A Systematic Review and Meta-Analysis
Background Transoral outlet reduction (TORe) is increasingly performed for recurrent weight gain or suboptimal clinical response after Roux-en-Y gastric bypass (RYGB). However, the durability of outcomes beyond one year remains uncertain. Methods A systematic review and meta-analysis was conducted following PRISMA guidelines. Six databases were searched to June 2025 for RCTs and cohort studies of adults undergoing TORe after RYGB with ≥ 12 months of follow-up. Outcomes included % total weight loss (%TWL), % excess weight loss (%EWL), and adverse events (AEs). Data were pooled using random effects restricted maximum likelihood models. Results Twenty-five studies (3 RCTs, 22 observational; 2667 patients) were included. Pooled baseline age was 47.3 years, 86.0% were female, mean BMI was 38.0 kg/m², and mean interval from RYGB to TORe was 9.5 years. At 12 months, pooled %TWL was 8.0% (95% CI 6.3–9.7) and pooled %EWL was 20.3% (95% CI 14.1–26.5). Weight loss declined at longer follow-up, with pooled estimates of 7.7% TWL and 16.3% EWL at 24 months, and 4% TWL at 36 months. In meta-regression, years since RYGB predicted greater %TWL and %EWL. The pooled AE rate was 5% (95% CI 3–7%), and the pooled SAE rate was 0.3% (95% CI 0.1–0.5%), with no procedure-related mortality. Conclusion TORe can provide modest but clinically meaningful weight loss at 12 months with a low rate of serious AE although durability beyond two years appears limited. It may be best regarded as an anatomically corrective intervention that is most effective when incorporated into comprehensive, long-term obesity management.
- 26 March 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (5) , 2753-2756
Surgical endoscopy a historical perspective for the future
Background Flexible endoscopy today is often assumed to be the exclusive domain of medical gastroenterologists. Surgeons however, have been, and continue to be, pioneers and practitioners of endoscopy, significantly advancing this minimally invasive field through their contributions. Methods We present a historical review of the contributions surgeons have made in the creation and practice of flexible endoscopy — and offer our vision of the course of future collaborative development of the field. Results Surgical endoscopists have and continue to have a tremendous impact on both the technology and techniques of flexible endoscopy. While the involvement of surgeons in flexible endoscopy varies from country to country, it remains a fundamental component of surgical training and an important part of the practice of many surgeons. Conclusion Flexible endoscopy has always been and continues to be an important patient care tool that is shared between medical gastroenterology and digestive surgery. “Turf war” efforts to restrict access to this important tool are unjustified and only serve to deprive patients of the dramatic benefits this tool offers.
- 26 March 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (5) , 2753-2756
Surgical endoscopy a historical perspective for the future
Background Flexible endoscopy today is often assumed to be the exclusive domain of medical gastroenterologists. Surgeons however, have been, and continue to be, pioneers and practitioners of endoscopy, significantly advancing this minimally invasive field through their contributions. Methods We present a historical review of the contributions surgeons have made in the creation and practice of flexible endoscopy — and offer our vision of the course of future collaborative development of the field. Results Surgical endoscopists have and continue to have a tremendous impact on both the technology and techniques of flexible endoscopy. While the involvement of surgeons in flexible endoscopy varies from country to country, it remains a fundamental component of surgical training and an important part of the practice of many surgeons. Conclusion Flexible endoscopy has always been and continues to be an important patient care tool that is shared between medical gastroenterology and digestive surgery. “Turf war” efforts to restrict access to this important tool are unjustified and only serve to deprive patients of the dramatic benefits this tool offers.
- Top Cited PapersOpen Access
- 4 February 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (4) , 2791-2809
Essential components and validation of multi-specialty robotic surgical training curricula: a systematic review
Introduction: The rapid adoption of robotic surgical systems has overtook the development of standardized training and competency assessment for surgeons, resulting in an unmet educational need in this field. This systematic review aims to identify the essential components and evaluate the validity of current robotic training curricula across all surgical specialties. Methods: A systematic search of MEDLINE, EMBASE, Emcare, and CINAHL databases was conducted to identify the studies reporting on multi-specialty or specialty-specific surgical robotic training curricula, between January 2000 and January 2024. We extracted the data according to Kirkpatrick’s curriculum evaluation model and Messick’s concept of validity. The quality of studies was assessed using the Medical Education Research Study Quality Instrument (MERSQI). Results: From the 3687 studies retrieved, 66 articles were included. The majority of studies were single-center (n = 52, 78.8%) and observational (n = 58, 87.9%) in nature. The most commonly reported curriculum components include didactic teaching (n = 48, 72.7%), dry laboratory skills (n = 46, 69.7%), and virtual reality (VR) simulation (n = 44, 66.7%). Curriculum assessment methods varied, including direct observation (n = 44, 66.7%), video assessment (n = 26, 39.4%), and self-assessment (6.1%). Objective outcome measures were used in 44 studies (66.7%). None of the studies were fully evaluated according to Kirkpatrick’s model, and five studies (7.6%) were fully evaluated according to Messick’s framework. The studies were generally found to have moderate methodological quality with a median MERSQI of 11. Conclusions: Essential components in robotic training curricula identified were didactic teaching, dry laboratory skills, and VR simulation. However, variability in assessment methods used and notable gaps in curricula validation remain evident. This highlights the need for standardized evidence-based development, evaluation, and reporting of robotic curricula to ensure the effective and safe adoption of robotic surgical systems.
- 4 February 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (4) , 2791-2809
Top Cited PapersOpen AccessEssential components and validation of multi-specialty robotic surgical training curricula: a systematic review
Introduction: The rapid adoption of robotic surgical systems has overtook the development of standardized training and competency assessment for surgeons, resulting in an unmet educational need in this field. This systematic review aims to identify the essential components and evaluate the validity of current robotic training curricula across all surgical specialties. Methods: A systematic search of MEDLINE, EMBASE, Emcare, and CINAHL databases was conducted to identify the studies reporting on multi-specialty or specialty-specific surgical robotic training curricula, between January 2000 and January 2024. We extracted the data according to Kirkpatrick’s curriculum evaluation model and Messick’s concept of validity. The quality of studies was assessed using the Medical Education Research Study Quality Instrument (MERSQI). Results: From the 3687 studies retrieved, 66 articles were included. The majority of studies were single-center (n = 52, 78.8%) and observational (n = 58, 87.9%) in nature. The most commonly reported curriculum components include didactic teaching (n = 48, 72.7%), dry laboratory skills (n = 46, 69.7%), and virtual reality (VR) simulation (n = 44, 66.7%). Curriculum assessment methods varied, including direct observation (n = 44, 66.7%), video assessment (n = 26, 39.4%), and self-assessment (6.1%). Objective outcome measures were used in 44 studies (66.7%). None of the studies were fully evaluated according to Kirkpatrick’s model, and five studies (7.6%) were fully evaluated according to Messick’s framework. The studies were generally found to have moderate methodological quality with a median MERSQI of 11. Conclusions: Essential components in robotic training curricula identified were didactic teaching, dry laboratory skills, and VR simulation. However, variability in assessment methods used and notable gaps in curricula validation remain evident. This highlights the need for standardized evidence-based development, evaluation, and reporting of robotic curricula to ensure the effective and safe adoption of robotic surgical systems.
- Open Access
- 15 November 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (12) , 4349
Correction: IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management
- 15 November 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (12) , 4349
Open AccessCorrection: IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management
- Open Access
- 1 November 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (12) , 4318-4348
IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management
Background: Obesity is a significant global health issue. Metabolic and bariatric surgery (MBS) is the gold standard in the treatment of obesity due to its proven effectiveness and safety in the short and long term. However, MBS is not suitable for all patients. Some individuals are at high surgical risk or refuse surgical treatment, while others do not meet the criteria for MBS despite having obesity-related comorbidities. This gap has driven the development of endoscopic solutions like endoscopic sleeve gastroplasty (ESG), which offers a less invasive alternative that preserves organ function and reduces risks. A recent IFSO International Delphi consensus study highlighted that multidisciplinary experts agree on the utility of ESG for managing obesity in patients with class I and II obesity and for those with class III obesity who do not wish to pursue or qualify for MBS. This IFSO Bariatric Endoscopy Committee position statement aims to augment these consensus statements by providing a comprehensive systematic review of the evidence and delivering an evidence-based position on the value of ESG within the spectrum of obesity management. Methods: A comprehensive systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Cochrane guidelines. Results: Systematic Review: The systematic review included 44 articles encompassing 15,714 patients receiving ESG. The studies varied from large case series to cohort studies and a randomized controlled trial (RCT). The mean baseline BMI was 37.56 kg/m2. The review focused on weight loss outcomes and safety data. Meta-analysis: Time point Mean %EWL Mean%TBWL 6 months 48.04 15.66 12 months 53.09 17.56 18 months 57.98 16.25 24 months 46.57 15.2 36 months 53.18 14.07 60 months 45.3 15.9 These results demonstrate significant weight loss following ESG. Safety: The pooled serious adverse event (SAE) rate was 1.25%. This low rate of SAEs indicates that ESG is a relatively safe procedure. Quality of Evidence: The quality of evidence from the included observational studies was assessed as very low, primarily due to the inherent limitations associated with observational study designs, such as potential biases and lack of randomization. In contrast, the quality of evidence from the single randomized controlled trial was rated as MODERATE, reflecting a more robust study design that provides a higher level of evidence despite some limitations. Conclusions: The IFSO Bariatric Endoscopy Committee, after conducting a comprehensive systematic review and meta-analysis, endorses endoscopic sleeve gastroplasty (ESG) as an effective and valuable treatment for obesity. ESG is particularly beneficial for patients with class I and II obesity, as well as for those with class III obesity who are not suitable candidates for metabolic bariatric surgery. ESG provides significant weight loss outcomes and demonstrates a favorable safety profile with a low rate of serious adverse events. Despite the limitations of the included observational studies, the randomized controlled trial included in the analysis reinforces the efficacy and safety of ESG and provides an evidence-based foundation for the position statement. Thus, the IFSO position statement supports and provides an evidence base for the role of ESG within the broader spectrum of obesity management.
- 1 November 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (12) , 4318-4348
Open AccessIFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management
Background: Obesity is a significant global health issue. Metabolic and bariatric surgery (MBS) is the gold standard in the treatment of obesity due to its proven effectiveness and safety in the short and long term. However, MBS is not suitable for all patients. Some individuals are at high surgical risk or refuse surgical treatment, while others do not meet the criteria for MBS despite having obesity-related comorbidities. This gap has driven the development of endoscopic solutions like endoscopic sleeve gastroplasty (ESG), which offers a less invasive alternative that preserves organ function and reduces risks. A recent IFSO International Delphi consensus study highlighted that multidisciplinary experts agree on the utility of ESG for managing obesity in patients with class I and II obesity and for those with class III obesity who do not wish to pursue or qualify for MBS. This IFSO Bariatric Endoscopy Committee position statement aims to augment these consensus statements by providing a comprehensive systematic review of the evidence and delivering an evidence-based position on the value of ESG within the spectrum of obesity management. Methods: A comprehensive systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Cochrane guidelines. Results: Systematic Review: The systematic review included 44 articles encompassing 15,714 patients receiving ESG. The studies varied from large case series to cohort studies and a randomized controlled trial (RCT). The mean baseline BMI was 37.56 kg/m2. The review focused on weight loss outcomes and safety data. Meta-analysis: Time point Mean %EWL Mean%TBWL 6 months 48.04 15.66 12 months 53.09 17.56 18 months 57.98 16.25 24 months 46.57 15.2 36 months 53.18 14.07 60 months 45.3 15.9 These results demonstrate significant weight loss following ESG. Safety: The pooled serious adverse event (SAE) rate was 1.25%. This low rate of SAEs indicates that ESG is a relatively safe procedure. Quality of Evidence: The quality of evidence from the included observational studies was assessed as very low, primarily due to the inherent limitations associated with observational study designs, such as potential biases and lack of randomization. In contrast, the quality of evidence from the single randomized controlled trial was rated as MODERATE, reflecting a more robust study design that provides a higher level of evidence despite some limitations. Conclusions: The IFSO Bariatric Endoscopy Committee, after conducting a comprehensive systematic review and meta-analysis, endorses endoscopic sleeve gastroplasty (ESG) as an effective and valuable treatment for obesity. ESG is particularly beneficial for patients with class I and II obesity, as well as for those with class III obesity who are not suitable candidates for metabolic bariatric surgery. ESG provides significant weight loss outcomes and demonstrates a favorable safety profile with a low rate of serious adverse events. Despite the limitations of the included observational studies, the randomized controlled trial included in the analysis reinforces the efficacy and safety of ESG and provides an evidence-based foundation for the position statement. Thus, the IFSO position statement supports and provides an evidence base for the role of ESG within the broader spectrum of obesity management.